CBSC announces $375,000 Noventis Medical purchase order and new recurring revenue program for MyCardia AT cardiac monitoring devices.

Sep 11

Cardiac Biotech

Cardiac Biotech

CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical

CBSC secures $375K purchase order with Noventis Medical and launches recurring revenue program for MyCardia AT devices.
Cardiac Biotech Solutions signs exclusive $600K Noventis Medical distribution agreement for Latin America.

Sep 04

Cardiac Biotech

Cardiac Biotech

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Cardiac Biotech Solutions, Inc. signs $600K exclusive distribution deal with Noventis Medical, expanding cardiac monitoring reach into Latin America.

How can we help you?

Contact Us

© 2020-2026. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.